Home

News

8 New Square named Legal 500 IP, IT and Media Set of the year 20193 January 2019
Glaxo Group Ltd and Ors v Vectura Ltd [2018] EWHC 3414 (Pat)13 December 2018Andrew Lykiardopoulos QC, alongside Anna Edwards-Stuart of 11 South Square, appeared for the Defendant, the proprietor of five patents concerning both the manufacture of particles to be used in pharmaceutical compositions for inhalation and the compositions themselves. The Defendant alleged that the Claimants had infringed its patents by the manufacture and sale of certain dried […]
Dr Eleonora Rosati included in MIP29 November 2018Dr Eleonora Rosati, Door Tenant at 8 New Square and Associate Professor in IP Law at the University of Southampton, has been included in Managing Intellectual Property’s 2018 ‘The 50 Most Influential People in IP’ list. The list recognizes individuals who are shaping IP law, policy and business throughout the world. It has typically included […]
Copyright and the Court of Justice of the European Union – book launch February 201927 November 2018A new monograph by Dr Eleonora Rosati, a Door Tenant at 8 New Square, is currently in the process of publication with Oxford University Press and is due for release in February 2019. Copyright and the Court of Justice of the European Union focuses specifically on the role, action, and legacy of the CJEU in […]
Laddie, Prescott and Vitoria: The Modern Law of Copyright (5th Edition), published November 201822 November 2018When it was first published over 25 years ago, Hugh Laddie, Peter Prescott and Mary Vitoria’s work ’The Modern Law of Copyright’ set a new standard for legal textbooks with its unique style and approach. Ever since, Chambers has been proud to be associated with ‘LPV’ and keen to maintain its place as a leading […]
Warner Lambert v Generics (UK) t/a Mylan [2018] UKSC 5614 November 2018Adrian Speck QC, alongside Pushpinder Saini QC of Blackstone Chambers and Kathryn Pickard of 11 South Square, appeared for the Respondents in Warner-Lambert’s appeal to the Supreme Court regarding their Swiss-form patent for the drug pregabalin. The appeal raised important questions concerning the role of plausibility in the test for insufficiency and the determination of […]
Warner Lambert Company LLC v Generics (UK) Ltd. t/a Mylan and Another [2018] UKSC 5614 November 2018Adrian Speck QC, alongside Pushpinder Saini QC of Blackstone Chambers and Kathryn Pickard of 11 South Square, appeared for the Respondents in Warner-Lambert’s appeal to the Supreme Court regarding their Swiss-form patent for the drug pregabalin. The appeal raised important questions concerning the role of plausibility in the test for insufficiency and the determination of […]
British Broadcasting Corporation and BBC Worldwide Ltd v Mechanical-Copyright Protection Society Ltd and Performing Right Society Ltd; Sky Ltd and ITV Networks Ltd intervening [2018] EWHC 2931 (Ch)6 November 2018Lindsay Lane, alongside Rhodri Thompson QC of Matrix Chambers, appeared for the Respondents, the BBC. Martin Howe QC and Michael Conway appeared for Sky, intervening. The appeal related to decision of the Copyright Tribunal on a preliminary issue in a reference brought by the BBC, concerning the Tribunal’s jurisdiction to settle the terms of copyright […]
Astex Therapeutics v AstraZeneca AB [2018] EWCA Civ 24446 November 2018The Court of Appeal upheld the decision of the trial judge in favour of AstraZeneca in relation to a contractual drug development dispute. The parties had engaged in a collaborative research program (the Program) aimed at identifying a drug suitable for inhibiting the BACE enzyme, thought to be involved in the development of Alzheimer’s disease. […]
Astex Therapeutics Ltd v AstraZeneca AB [2018] EWCA Civ 24446 November 2018The Court of Appeal upheld the decision of the trial judge in favour of AstraZeneca in relation to a contractual drug development dispute. The parties had engaged in a collaborative research program (the Program) aimed at identifying a drug suitable for inhibiting the BACE enzyme, thought to be involved in the development of Alzheimer’s disease. […]